MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 742.57 Million EUR | 5.06% |
| 2022 | 706.78 Million EUR | 1.23% |
| 2021 | 698.21 Million EUR | -1.75% |
| 2020 | 710.61 Million EUR | 0.51% |
| 2019 | 707 Million EUR | 179.08% |
| 2018 | 253.33 Million EUR | 38.16% |
| 2017 | 183.36 Million EUR | 10.8% |
| 2016 | 165.49 Million EUR | 3.25% |
| 2015 | 160.28 Million EUR | -3.25% |
| 2014 | 165.66 Million EUR | 3.1% |
| 2013 | 160.67 Million EUR | -1.17% |
| 2012 | 162.57 Million EUR | -0.41% |
| 2011 | 163.24 Million EUR | -4.77% |
| 2010 | 171.41 Million EUR | -2.89% |
| 2009 | 176.51 Million EUR | -9.14% |
| 2008 | 194.26 Million EUR | 17.21% |
| 2007 | 165.74 Million EUR | -2.48% |
| 2006 | 169.96 Million EUR | -5.97% |
| 2005 | 180.74 Million EUR | -35.44% |
| 2004 | 279.97 Million EUR | -0.09% |
| 2003 | 280.22 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 691.14 Million EUR | -2.08% |
| 2024 Q1 | 705.78 Million EUR | -4.95% |
| 2023 Q2 | 691.93 Million EUR | -2.56% |
| 2023 Q1 | 710.13 Million EUR | 0.47% |
| 2023 Q3 | 685.66 Million EUR | -0.91% |
| 2023 Q4 | 742.57 Million EUR | 8.3% |
| 2023 FY | 742.57 Million EUR | 5.06% |
| 2022 Q2 | 647.21 Million EUR | -6.75% |
| 2022 Q4 | 706.78 Million EUR | 11.11% |
| 2022 FY | 706.78 Million EUR | 1.23% |
| 2022 Q3 | 636.09 Million EUR | -1.72% |
| 2022 Q1 | 694.07 Million EUR | -0.59% |
| 2021 Q1 | 716.29 Million EUR | 0.8% |
| 2021 Q4 | 698.21 Million EUR | -1.53% |
| 2021 Q2 | 712.1 Million EUR | -0.58% |
| 2021 Q3 | 709.04 Million EUR | -0.43% |
| 2021 FY | 698.21 Million EUR | -1.75% |
| 2020 Q3 | 728.58 Million EUR | 0.64% |
| 2020 Q2 | 723.94 Million EUR | 2.6% |
| 2020 FY | 710.61 Million EUR | 0.51% |
| 2020 Q1 | 705.59 Million EUR | -0.2% |
| 2020 Q4 | 710.61 Million EUR | -2.47% |
| 2019 Q3 | 702.92 Million EUR | -0.03% |
| 2019 Q2 | 703.12 Million EUR | -0.21% |
| 2019 Q1 | 704.59 Million EUR | 178.13% |
| 2019 FY | 707 Million EUR | 179.08% |
| 2019 Q4 | 707 Million EUR | 0.58% |
| 2018 Q1 | 234.66 Million EUR | 27.98% |
| 2018 FY | 253.33 Million EUR | 38.16% |
| 2018 Q4 | 253.33 Million EUR | 5.56% |
| 2018 Q3 | 239.98 Million EUR | 4.13% |
| 2018 Q2 | 230.46 Million EUR | -1.79% |
| 2017 Q2 | 163.03 Million EUR | -3.55% |
| 2017 Q3 | 164.84 Million EUR | 1.11% |
| 2017 Q4 | 183.36 Million EUR | 11.24% |
| 2017 Q1 | 169.03 Million EUR | 2.14% |
| 2017 FY | 183.36 Million EUR | 10.8% |
| 2016 Q2 | 168.82 Million EUR | -2.1% |
| 2016 FY | 165.49 Million EUR | 3.25% |
| 2016 Q3 | 179.34 Million EUR | 6.23% |
| 2016 Q1 | 172.45 Million EUR | 7.59% |
| 2016 Q4 | 165.49 Million EUR | -7.72% |
| 2015 Q4 | 160.28 Million EUR | -6.34% |
| 2015 Q3 | 171.14 Million EUR | 1.15% |
| 2015 Q1 | 180.94 Million EUR | 9.22% |
| 2015 Q2 | 169.2 Million EUR | -6.49% |
| 2015 FY | 160.28 Million EUR | -3.25% |
| 2014 Q2 | 166.96 Million EUR | 0.52% |
| 2014 Q3 | 168.84 Million EUR | 1.13% |
| 2014 Q1 | 166.1 Million EUR | 3.38% |
| 2014 Q4 | 165.66 Million EUR | -1.88% |
| 2014 FY | 165.66 Million EUR | 3.1% |
| 2013 Q4 | 160.67 Million EUR | -0.4% |
| 2013 Q2 | 160.49 Million EUR | -1.18% |
| 2013 Q1 | 162.4 Million EUR | -0.11% |
| 2013 FY | 160.67 Million EUR | -1.17% |
| 2013 Q3 | 161.32 Million EUR | 0.52% |
| 2012 FY | 162.57 Million EUR | -0.41% |
| 2012 Q3 | 155.62 Million EUR | 0.03% |
| 2012 Q1 | 157.91 Million EUR | -3.26% |
| 2012 Q4 | 162.57 Million EUR | 4.47% |
| 2012 Q2 | 155.57 Million EUR | -1.48% |
| 2011 Q1 | 172.79 Million EUR | 0.81% |
| 2011 Q2 | 165.5 Million EUR | -4.22% |
| 2011 Q3 | 176.63 Million EUR | 6.73% |
| 2011 Q4 | 163.24 Million EUR | -7.58% |
| 2011 FY | 163.24 Million EUR | -4.77% |
| 2010 Q3 | 175.42 Million EUR | -0.17% |
| 2010 Q4 | 171.41 Million EUR | -2.28% |
| 2010 Q2 | 175.71 Million EUR | -0.92% |
| 2010 Q1 | 177.34 Million EUR | 0.47% |
| 2010 FY | 171.41 Million EUR | -2.89% |
| 2009 Q4 | 176.51 Million EUR | 0.0% |
| 2009 FY | 176.51 Million EUR | -9.14% |
| 2008 FY | 194.26 Million EUR | 17.21% |
| 2007 FY | 165.74 Million EUR | -2.48% |
| 2006 FY | 169.96 Million EUR | -5.97% |
| 2005 FY | 180.74 Million EUR | -35.44% |
| 2004 FY | 279.97 Million EUR | -0.09% |
| 2003 FY | 280.22 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.1 Billion EUR | 96.113% |
| Fresenius SE & Co. KGaA | 25.63 Billion EUR | 97.103% |
| LIMES Schlosskliniken AG | 16.6 Million EUR | -4371.875% |
| M1 Kliniken AG | 69.72 Million EUR | -964.944% |
| Maternus-Kliniken Aktiengesellschaft | 206.49 Million EUR | -259.613% |
| RHÖN-KLINIKUM Aktiengesellschaft | 499.09 Million EUR | -48.784% |
| VITA 34 AG | 135.58 Million EUR | -447.702% |